SUTRO BIOPHARMA, INC. vs Lineage Cell Therapeutics, Inc., risk disclosures compared

4topics both disclose

5only SUTRO BIOPHARMA, INC.

4only Lineage Cell Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	SUTRO BIOPHARMA, INC.	Lineage Cell Therapeutics, Inc.
Business Continuity	25	11
Ransomware	3	14
Internal Control	5	3
Restatement	2	1

Only SUTRO BIOPHARMA, INC.

Topic	Filings
Material Weakness	5
Regulatory Investigation	4
Third Party Risk Management	3
Records Retention	2
Regulatory Reporting	1

Only Lineage Cell Therapeutics, Inc.

Topic	Filings
Data Residency	5
ESG Reporting	4
Audit Committee Oversight	3
Cross Border Data Transfer	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

SUTRO BIOPHARMA, INC. · Lineage Cell Therapeutics, Inc. · All companies